MOLCURE Inc.
PrivateLast Round
Series C
Aug 18, 2021
Est. Valuation
$23.58M
Total Funding Raised
$13.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
MOLCURE Inc. is a biotechnology company that provides an AI-driven platform for drug discovery, leveraging machine learning and a proprietary database to design and identify novel antibodies and peptides for pharmaceutical partners.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MOLCURE Inc. Comparables
Compare MOLCURE Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LabGenius Therapeutics | 86% | |
| Antiverse | 86% | |
| BigHat Biosciences | 85% | |
MOLCURE Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 18, 2021 | ||||
| Series B | Nov 27, 2018 | ||||
| Grant | Sep 1, 2016 | ||||
| Series A | Sep 29, 2014 |
Key People
Founding team and executive leadership
MOLCURE Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JAFCO Group Co., Ltd. | Series C |
| Japan Post Capital | Series C |
| UTEC (The University of Tokyo Edge Capital Partners) | Series A |
| New Energy and Industrial Technology Development Organization | Grant |
| GMO VenturePartners | Series B, Series C |
| Strive | Series C |
| STRIVE | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2026
Attending the AI:360 Conference in California in November 2026.
- Nov 1, 2026
Invited to present at the AI:360 Conference in November 2026.
MOLCURE Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MOLCURE Inc.'s valuation, stock price, and market status.